The hallmark of Crohn's disease (CD) is systemic inflammation, along with intestinal inflammation that extends through all layers of the gut wall. Hyperbaric Oxygen (HBOT) has been shown to cause a significant reduction in the inflammatory markers in CD while also showing clinical improvements in these patients. Emerging evidence suggests that gut microbiota plays a predominant role in in CD and is associated with the progression of CD. Since HBOT has been shown to regulate gut microbiota, this study was aimed to observe the effects in CD. Their findings demonstrated that HBOT was able to mitigate the altered composition of gut microbiota and improve the reduced microbial diversity found in CD.  By regulating the gut micorbiota, HBOT was able to help ameliorate intestinal inflammation along with systemic inflammation.<view study>     Read Less

This study included a group of fibromyalgia-diagnosed w0men taking a full course of 40 hyperbaric oxygen sessions at 1.45 ATA (90 minutes per session, 5 days per week, for a total of 8 weeks). Follow up results showed significant improvements in pain threshold <view study> Read Less

This 2021 review of literature suggest benefit for using hyperbaric oxygen therapy in ulcerative colitis flares and Crohn's disease <view study> Read Less

Atopic dermatitis (eczema) or AD is a condition that makes your skin red and itchy and is one of the most common inflammatory skin diseases in children. As the disease progresses in severity the consequences can be seen in sleeping disturbances, irritability, stress and social functioning disorders. After only a the 30-day treatment cycle in a hyperbaric chamber, all children with severe atopic dermatitis experienced a significant clinical improvement in their skin condition. There was a reduction in the extent and intensity of skin lesions, as well as a reduction of redness, swelling, oozing/crusting, scratch marks and skin lichenification. Moreover, patients reported a noticeable reduction in the intensity of pruritus (itching) and an improvement in sleep quality! These results are very promising and should give rise to more research into effective treatment dosages and protocols. This particular study used 2.5 ATA for 60 minutes (three 20 min sessions separated by two 5 minute air breaks).  <view study> Read Less

The benefits of hyperbaric oxygen therapy for dramatic brain injury (TBI) has been confirmed by many studies. Now the question is “what is the best dose (ie, pressure protocol) to achieve the optimal benefits. As new research becomes available, it appears that the lower the pressure, the stronger the benefits. This study confirms the recent data, by showing that 1.6 ATA hyperbaric intervention was superior to 2.2ATA for neurological impairment and the restoration of symptoms following TBI. Researchers in this study suggested that “for the first time that 1.6 ATA HBO has an important protective role in inhibiting both the cytotoxic and the pro-inflammatory actions of histones in the early stage of secondary brain injury”. <view study> Read Less